DrugDashboards

Se-Tan PLUS

Multivitamin/Mineral · FERROUS FUMARATE 162 mg/1; IRON DEXTRAN 115.2 mg/1; SODIUM ASCORBATE 200 mg/1; THIAMINE MONONITRATE 10 mg/1; RIBOFLAVIN 6 mg/1; PYRIDOXINE HYDROCHLORIDE 5 mg/1; CYANOCOBALAMIN 15 ug/1; FOLIC ACID 1 mg/1; NIACINAMIDE 30 ug/1; CALCIUM PANTOTHENATE 10 mg/1; ZINC SULFATE 18.2 mg/1; MANGANESE SULFATE 1.3 mg/1; CUPRIC SULFATE .8 mg/1 · Capsule, Gelatin Coated · Oral · Seton Pharmaceuticals

NDC 13925-0118-90 · 90 CAPSULE, GELATIN COATED in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.3921 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.25$0.5$0.75Oct 2013Sep 2026$0.3921
57 price points · per EA · held since Invalid DateSource: CMS NADAC

Estimated fill cost

#30 count
$11.76
#90 count
$35.29

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$16,295
962 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.0%chance of a new FDA shortage posting for multivitamin/mineral (oral solid) in the next 90 days

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Multivitamin/Mineral (Capsule, Gelatin Coated)

LabelerStrengthFirst seenLast seen
Seton PharmaceuticalsFERROUS FUMARATE 162 mg/1; IRON DEXTRAN 115.2 mg/1; SODIUM ASCORBATE 200 mg/1; THIAMINE MONONITRATE 10 mg/1; RIBOFLAVIN 6 mg/1; PYRIDOXINE HYDROCHLORIDE 5 mg/1; CYANOCOBALAMIN 15 ug/1; FOLIC ACID 1 mg/1; NIACINAMIDE 30 ug/1; CALCIUM PANTOTHENATE 10 mg/1; ZINC SULFATE 18.2 mg/1; MANGANESE SULFATE 1.3 mg/1; CUPRIC SULFATE .8 mg/1Aug 26, 2026Sep 2, 2026
Seton PharmaceuticalsFERROUS FUMARATE 10 mg/1; IRON DEXTRAN .8 mg/1; SODIUM ASCORBATE 15 ug/1; THIAMINE MONONITRATE 162 mg/1; RIBOFLAVIN 1 mg/1; PYRIDOXINE HYDROCHLORIDE 115.2 mg/1; CYANOCOBALAMIN 1.3 mg/1; FOLIC ACID 30 ug/1; NIACINAMIDE 5 mg/1; CALCIUM PANTOTHENATE 6 mg/1; ZINC SULFATE 200 mg/1; MANGANESE SULFATE 10 mg/1; CUPRIC SULFATE 18.2 mg/1Jul 22, 2026Aug 19, 2026
Seton PharmaceuticalsCALCIUM PANTOTHENATE 10 mg/1; CUPRIC SULFATE .8 mg/1; CYANOCOBALAMIN 15 ug/1; FERROUS FUMARATE 162 mg/1; FOLIC ACID 1 mg/1; IRON DEXTRAN 115.2 mg/1; MANGANESE SULFATE 1.3 mg/1; NIACINAMIDE 30 ug/1; PYRIDOXINE HYDROCHLORIDE 5 mg/1; RIBOFLAVIN 6 mg/1; SODIUM ASCORBATE 200 mg/1; THIAMINE MONONITRATE 10 mg/1; ZINC SULFATE 18.2 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Se-Tan PLUS — NDC 13925-0118-90," retrieved September 3, 2026, https://drugdashboards.com/drug/13925011890.

Free to cite with attribution — see how the data is put together.